Revolutionary retinal implant restores central vision in 80% of patients with advanced macular degeneration, offering hope ...
AI-powered retinal imaging closes healthcare gaps, enables earlier intervention, and reveals new insights into systemic ...
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of ...
A groundbreaking retinal implant, PRIMA, is restoring central vision in patients with geographic atrophy (GA), an advanced ...
For the first time, scientists have managed to restore central vision loss from an irreversible age-related eye condition via ...
Dr. Andreas Wallnöfer joins Optigo Biotherapeutics' Board, bringing expertise from Jeito Capital, BioMedPartners, and Roche.
The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully ...
Optain, a startup that built AI-powered retinal screening technology, acquired EyePACS to add its teleophthalmology network and expand access to eye-disease screening in primary care.
Dr Sunir Garg shares insights on patient management, medication impact, and advancing technologies that are shaping the ...
FORT WORTH, Texas & MELBOURNE, Australia & MENLO PARK, Calif., November 05, 2025--PolyActiva, a clinical-stage ...
4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...
It’s been a long-held assumption that the human eye is capable of detecting a maximum of 60 pixels per degree (PPD), which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback